---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-006137"
form_type: "8-K"
ticker: null
cik: "0001623715"
company_name: "Imago BioSciences, Inc."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:33:37.155251+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Merck completes $36/share acquisition of Imago BioSciences; shares delisted

## Summary
- Merck acquired all shares of Imago for $36.00 cash per share via tender offer and merger on Jan 11, 2023.
- Approximately 89.2% of shares (31,307,028) were tendered, satisfying all conditions.
- Imago becomes wholly owned subsidiary of Merck; shares no longer listed on Nasdaq.
- Imago's board of directors replaced by Merck appointees; charter and bylaws amended.

## SEC filing metadata
- accession: 0001193125-23-006137
- form_type: 8-K
- cik: 0001623715
- company_name: Imago BioSciences, Inc.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/d514174d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-006137
- JSON: https://secwatch.observer/filing/0001193125-23-006137.json
- Plain text: https://secwatch.observer/filing/0001193125-23-006137.txt

## Key facts
- Executive change
  Jon Filderman was appointed as Vice President at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Vice President
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Dina Chaya, Ph.D. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Laurie Keating J.D. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Gary A. Henningsen, Jr. was appointed as Senior Vice President – Tax at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Senior Vice President – Tax
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Aaron Rosenberg was appointed as Director at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Director
  source text: The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Robert Baltera, M.S. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Karen Ettelman was appointed as Assistant Secretary at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Assistant Secretary
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Enoch Kariuki, Pharm.D. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Jon Filderman was appointed as Director at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Director
  source text: The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Hugh Y. Reinhoff, Jr., M.D. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Robert V. Smartwood was appointed as Assistant Treasurer at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Assistant Treasurer
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Rita A. Karachun was appointed as President at Imago BioSciences, Inc..
  - Action: appointed
  - Role: President
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Aaron Rosenberg was appointed as Senior Vice President and Treasurer at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Senior Vice President and Treasurer
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Kelly E.W. Grez was appointed as Secretary at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Secretary
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Anthony Wildasin was appointed as Assistant Secretary at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Assistant Secretary
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Juanita Lee was appointed as Assistant Treasurer at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Assistant Treasurer
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Timothy G. Dillane was appointed as Assistant Treasurer at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Assistant Treasurer
  source text: The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Rita A. Karachun was appointed as Director at Imago BioSciences, Inc..
  - Action: appointed
  - Role: Director
  source text: The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Executive change
  Dennis Henner, Ph.D. departed as Director at Imago BioSciences, Inc..
  - Action: ceased to be a director
  - Role: Director
  source text: Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Governance Changes
  Imago BioSciences, Inc.: Amended and restated by-laws in their entirety.
  - Change: bylaw amendment
  source text: Imago’s by-laws, as in effect immediately prior to the Effective Time, were amended and restated in their entirety (the “Second Amended and Restated By-Laws”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- Governance Changes
  Imago BioSciences, Inc.: Amended and restated certificate of incorporation in its entirety.
  - Change: charter amendment
  source text: Imago’s certificate of incorporation, as in effect immediately prior to the Effective Time, was amended and restated in its entirety (the “Second Amended and Restated Certificate of Incorporation”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
- M&A Transactions
  Imago BioSciences, Inc. completed an acquisition involving Merck Sharp & Dohme LLC for $36.00 per share in cash (closed 2023-01-11).
  - Action: acquisition
  - Counterparty: Merck Sharp & Dohme LLC
  - Consideration: $36.00 per share in cash
  - Closing: 2023-01-11
  source text: Merger Sub commenced a tender offer (the “Offer”) on December 12, 2022 to acquire all of the outstanding shares of Imago’s common stock (the “Shares”) for a purchase price of $36.00 per Share, to the seller in cash, without interest and subject to any required tax withholding (the “Offer Price”). The Offer and related withdrawal rights expired as scheduled at
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
